What I found surprising about the general clinical success rate in the article is that getting product through phase 2 is the most difficult phase; getting through phase 3 is usually the most costly.
And, to clarify the graph, the NDA/BLA simply means submission, while the approval means the FDA approval of BLA.
I was amazed by the significance of filing BLA, since filing of BLA means 85.3% of approval in general from FDA for all types of drugs and 88% for biologic products. I guess when they say they are going to file for BLA, it's big. If its submission is accepted, it's actually quite close to FDA approval.
- Forums
- ASX - By Stock
- MSB
- MSB short selling data - 25th.Jan.2019
MSB short selling data - 25th.Jan.2019, page-5
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.8¢ |
Change
-0.018(1.76%) |
Mkt cap ! $1.138B |
Open | High | Low | Value | Volume |
99.0¢ | $1.03 | 97.5¢ | $2.455M | 2.467M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 15281 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 73944 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 30176 | 0.985 |
15 | 59158 | 0.980 |
9 | 59411 | 0.975 |
9 | 103287 | 0.970 |
8 | 108276 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 14267 | 9 |
0.995 | 44868 | 8 |
1.000 | 42414 | 8 |
1.005 | 42825 | 5 |
1.010 | 56734 | 9 |
Last trade - 15.53pm 05/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |